DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Minerva Neurosciences, Inc (NERV)
« Back to company indexNERV Chatter Timeline
Stock Ticker for NERV
Most Active Tweeters for NERV
| User | Tweets |
|---|---|
| @AmericanBanking | 3 |
| @SwingTradeBot | 2 |
| @1MinuteStock | 2 |
| @WeekHerald | 2 |
| @InsiderAlertsIA | 2 |
Recent Tweets for NERV
 |
@AmericanBanking Minerva Neurosciences Inc $NERV Major Shareholder Sells $113,260.50 in Stock https://t.co/ndCDLfJjQD #stocks June 17th 2019, 5:06pm |
 |
@EdgarPulse $NERV: Index Venture Associates III Ltd (10% Owner) disposed stocks worth $353,737 https://t.co/HAVv3rnqpA June 17th 2019, 4:06pm |
 |
@InsiderAlertsIA $NERV: New Insider Filing on 10%+ Owner INDEX VENTURE ASSOCIATES III LTD: https://t.co/PjkMi3UwyU June 17th 2019, 4:06pm |
 |
@SwingTradeBot New 52 Week Low today: $NERV ... https://t.co/0EM4q8YtyQ June 17th 2019, 2:06pm |
 |
@LargeVoidBot 14:05 New 52wk Lows: $NERV June 17th 2019, 2:06pm |
 |
@Russe9 $nerv 5 late-stage clinical efficacy trials ongoing w/ 3 product candidates,P3 trial w/ roluperidone MIN-101 for ne… https://t.co/hMSQEL7HJn June 13th 2019, 11:06pm |
 |
@TheMarketsDaily Minerva Neurosciences Inc $NERV Major Shareholder Sells $281,639.19 in Stock https://t.co/WNe1lQeHa7 June 13th 2019, 5:06pm |
|
@AmericanBanking Minerva Neurosciences Inc $NERV Major Shareholder Venture Associates L. Index III Sells 60,051 Shares https://t.co/OlFPjlylyE #stocks June 13th 2019, 5:06pm |
|
@InsiderAlertsIA $NERV: New Insider Filing on 10%+ Owner INDEX VENTURE ASSOCIATES III LTD: https://t.co/hQFWYkiU8i June 13th 2019, 5:06pm |
 |
@fintel_io Insider Yucca (Jersey) SLP reports selling 60,051 shares of $NERV for a total cost of $281,342.92 https://t.co/9gpUqgoN8U June 13th 2019, 5:06pm |
 |
@StockTexts $NERV Minerva Neurosciences, Inc SEC Filing: Form 4 https://t.co/hOoy4DWrsp June 13th 2019, 4:06pm |
|
@SwingTradeBot New 52 Week Low today: $SNDE $NERV ... https://t.co/0EM4q8YtyQ June 13th 2019, 3:06pm |
 |
@dispatchtribune Zacks: Analysts Anticipate Minerva Neurosciences Inc $NERV Will Announce Earnings of -$0.42 Per Share https://t.co/lPoDmjLqbo June 12th 2019, 8:06am |
|
@AmericanBanking Minerva Neurosciences Inc $NERV Expected to Post Earnings of -$0.42 Per Share https://t.co/QU8yQcf6GI #stocks June 9th 2019, 6:06am |
 |
@WeekHerald Zacks: Analysts Anticipate Minerva Neurosciences Inc $NERV to Post -$0.42 Earnings Per Share https://t.co/KnTotSY0G4 June 9th 2019, 6:06am |
 |
@storminvestor Analyzing Sesen Bio $SESN and Minerva Neurosciences $NERV https://t.co/JkOAAQE2x1 #markets June 9th 2019, 5:06am |
 |
@SleekMoneycom Analyzing Sesen Bio $SESN and Minerva Neurosciences $NERV https://t.co/9h4EVlpBQS #investing June 9th 2019, 5:06am |
 |
@stocknewstimes Analyzing Sesen Bio $SESN and Minerva Neurosciences $NERV https://t.co/jd2j25r9me June 9th 2019, 5:06am |
 |
@1MinuteStock We calculated 63-day Expected Return of $NERV for you: -32.44% https://t.co/7GbSnnXkwj June 8th 2019, 10:06pm |
|
@1MinuteStock Unicorn Bay rating for $NERV is 1.62 out of 5. https://t.co/Yw8Ovac3CC June 8th 2019, 10:06pm |
 |
@SeekingAlpha $NERV - Minerva Neurosciences (NERV) Investor Presentation - Slideshow https://t.co/OchlfMC8AM June 5th 2019, 12:06pm |
 |
@DeepSouthDoctor If you are bullish on $NERV Ph3 in neg sxs of schizoids (as I am given previous Ph2 data, and Ph3 design), then the… https://t.co/q2KpofubkL June 5th 2019, 11:06am |
 |
@OlympiaReport Minerva Neurosciences $NERV Now Covered by HC Wainwright https://t.co/klX7CMKzs2 June 4th 2019, 1:06am |
|
@WeekHerald Minerva Neurosciences $NERV Now Covered by HC Wainwright https://t.co/wSVNiRjY7O June 4th 2019, 1:06am |
|
@1MinuteStock Recommendation Moderate #SELL for $NERV with UB rating - 1.62 out of 5. https://t.co/TmDwkuCuhY June 3rd 2019, 7:06am |
|
@fintel_io $NERV / Minerva Neurosciences files form 8-K https://t.co/7vzIhg0O6v - Submission of Matters to a Vote of Security Holders June 3rd 2019, 6:06am |
 |
@dailypoliticaln HC Wainwright Begins Coverage on Minerva Neurosciences $NERV https://t.co/MgM5BTgaKm June 3rd 2019, 5:06am |
|
@TheMarketsDaily Head-To-Head Contrast: Sesen Bio $SESN vs. Minerva Neurosciences $NERV https://t.co/Yh51aFnetP June 2nd 2019, 12:06pm |
|
@AmericanBanking Comparing Sesen Bio $SESN & Minerva Neurosciences $NERV https://t.co/4AXTjXaZIc #stocks June 2nd 2019, 12:06pm |
|
@TheMarketsDaily Minerva Neurosciences $NERV Coverage Initiated by Analysts at HC Wainwright https://t.co/bEiKiBFSiQ June 2nd 2019, 5:06am |
|
@OlympiaReport Contrasting Dermira $DERM and Minerva Neurosciences $NERV https://t.co/XmvL3xiX9L June 1st 2019, 1:06am |
 |
@TheUnicornBay We calculated 63-day Expected Return of $NERV for you: -35.37% https://t.co/fzkxI3prnA May 31st 2019, 9:05pm |
|
@InsiderAlertsIA $NERV: New Insider Filing on Director JERYL L HILLEMAN: https://t.co/nz3dmOcXiz May 31st 2019, 5:05pm |
|
@StockTexts $NERV Minerva Neurosciences, Inc SEC Filing: Form 4 https://t.co/ZCv0Z0wDcD May 31st 2019, 5:05pm |
 |
@confcalltran Minerva director was just granted 20,000 options https://t.co/p3UUYtIH2b $NERV May 31st 2019, 5:05pm |
|
@confcalltran Minerva director was just granted 20,000 options https://t.co/kNYJaR7kcs $NERV May 31st 2019, 5:05pm |
 |
@firsttomarkets Minerva Neurosciences Inc Initiated Coverage by H.C. Wainwright (Ranked 82nd) to Buy $NERV #NERV https://t.co/9Bic9JKH5Q May 31st 2019, 9:05am |
 |
@Briefingcom $NERV: H.C. Wainwright starts at Buy May 31st 2019, 8:05am |
 |
@ThisLincolnian Minerva Neurosciences $NERV Receives New Coverage from Analysts at HC Wainwright https://t.co/nH5ZJPdT2f May 31st 2019, 7:05am |
|
@AmericanBanking Minerva Neurosciences $NERV Receives New Coverage from Analysts at HC Wainwright https://t.co/mbQWon5Isu #stocks May 31st 2019, 7:05am |
 |
@Algotrader7 $NERV SHORT @ 5.05 #DAYTRADING #swingtrader #stockmarket #stocktips #stocks May 30th 2019, 10:05am |
|
@AmericanBanking Reviewing Dermira $DERM & Minerva Neurosciences $NERV https://t.co/A29PhCWnE2 #stocks May 29th 2019, 4:05pm |
 |
@portefeuillefun Bought 600 $NERV at $5.24, now 1.2k #vssporte shares. May 29th 2019, 3:05pm |
 |
@ChartMill $NERV has a Current Ratio of 11.64, so it is financially healthy and has no problem in meeting its obligations.… https://t.co/NOij4ewzPK May 29th 2019, 12:05am |
 |
@NewsToDesk $NERV: Introducing Minerva Neurosciences (NASDAQ:NERV), The Stock …: https://t.co/jfQNz9M89S May 28th 2019, 3:05pm |
|
@1MinuteStock We calculated 63-day Expected Return of $NERV for you: -31.83% https://t.co/7GbSnnXkwj May 27th 2019, 2:05am |
|
@1MinuteStock Btw, Estimated #Earnings Per Share for $NERV is $-0.33 it's -6.15% of the current price https://t.co/NvzH3TWwpf May 27th 2019, 2:05am |
|
@1MinuteStock Wondering about risks of $NERV? The 63-day volatility is 25.4% https://t.co/45O6VTP8gm May 27th 2019, 1:05am |
|
@fintel_io Insider Yucca (Jersey) SLP reports selling 22,918 shares of $NERV for a total cost of $137,895.58 https://t.co/9gpUqgoN8U May 21st 2019, 4:05pm |
|
@InsiderAlertsIA $NERV: New Insider Filing on 10%+ Owner INDEX VENTURE ASSOCIATES III LTD: https://t.co/mSScr5rJSx May 21st 2019, 4:05pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.